Recent progress and new perspectives in lymphoma glycobiology.
暂无分享,去创建一个
[1] H. Stein,et al. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells , 2012, Laboratory Investigation.
[2] A. Ingle,et al. Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen–Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3 , 2009, Glycoconjugate Journal.
[3] L. Pinter-Brown. SGN-30: a basis for the effective treatment of CD30 positive hematopoietic malignancies , 2008 .
[4] D. Neuberg,et al. AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features , 2008, Clinical Cancer Research.
[5] O. Suzuki,et al. Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma. , 2008, Oncology reports.
[6] S. Monti,et al. The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma , 2007, Proceedings of the National Academy of Sciences.
[7] F. Goñi,et al. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. , 2006, Biochimica et biophysica acta.
[8] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.
[9] M. Abe,et al. Regulatory roles of altered N- and O-glycosylation of CD45 in galectin-1-induced cell death in human diffuse large B cell lymphoma. , 2005, International journal of oncology.
[10] S. Stowell,et al. Dimeric Galectin-1 Binds with High Affinity to α2,3-Sialylated and Non-sialylated Terminal N-Acetyllactosamine Units on Surface-bound Extended Glycans* , 2005, Journal of Biological Chemistry.
[11] A. Al-Shamkhani. The role of CD30 in the pathogenesis of haematopoietic malignancies. , 2004, Current opinion in pharmacology.
[12] R. Schauer. Sialic acids: fascinating sugars in higher animals and man. , 2004, Zoology.
[13] N. Taniguchi,et al. Expression of N-Acetylglucosaminyltransferase V Is Associated with Prognosis and Histology in Non-Small Cell Lung Cancers , 2004, Clinical Cancer Research.
[14] M. Teitell,et al. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. , 2004, The American journal of pathology.
[15] L. Baum,et al. Presentation of Galectin-1 by Extracellular Matrix Triggers T Cell Death* , 2004, Journal of Biological Chemistry.
[16] T. Yoshii,et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. , 2003, Cancer research.
[17] O. Suzuki,et al. Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and expression of N-acetylglucosaminyltransferase V in human diffuse large B cell lymphoma. , 2003, Oncology reports.
[18] O. Suzuki,et al. Sialic acids linked to glycoconjugates of Fas regulate the caspase-9-dependent and mitochondria-mediated pathway of Fas-induced apoptosis in Jurkat T cell lymphoma. , 2003, International journal of oncology.
[19] L. Baum,et al. The ST6Gal I Sialyltransferase Selectively ModifiesN-Glycans on CD45 to Negatively Regulate Galectin-1-induced CD45 Clustering, Phosphatase Modulation, and T Cell Death* , 2003, The Journal of Biological Chemistry.
[20] G. Rabinovich,et al. Role of galectins in inflammatory and immunomodulatory processes. , 2002, Biochimica et biophysica acta.
[21] R. Finley,et al. Galectin-3 Translocates to the Perinuclear Membranes and Inhibits Cytochrome c Release from the Mitochondria , 2002, The Journal of Biological Chemistry.
[22] O. Suzuki,et al. UDP-GlcNAc2-epimerase regulates cell surface sialylation and cell adhesion to extracellular matrix in Burkitt's lymphoma. , 2002, International journal of oncology.
[23] F. Goñi,et al. Membrane Restructuring via Ceramide Results in Enhanced Solute Efflux* , 2002, The Journal of Biological Chemistry.
[24] K. Knobeloch,et al. Sialylation is essential for early development in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Meijer,et al. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. , 2001, Journal of clinical pathology.
[26] L. Baum,et al. CD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O-Glycans1 , 2001, The Journal of Immunology.
[27] P. Lance,et al. Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. , 2001, Biochimica et biophysica acta.
[28] V. Gouyer,et al. Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern. , 2001, Journal of cell science.
[29] J. Dennis,et al. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.
[30] J. Marth,et al. Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Santini,et al. β‐galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with sambucus nigra agglutinin , 2000, International journal of cancer.
[32] 赤埴 詩朗. Galectin-3 : a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family , 2000 .
[33] S. Spiegel,et al. Involvement of Sphingosine in Mitochondria-dependent Fas-induced Apoptosis of Type II Jurkat T Cells* , 2000, The Journal of Biological Chemistry.
[34] Qiong Zhang,et al. Effects of H-ras and v-sis overexpression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells , 2000, Journal of Cancer Research and Clinical Oncology.
[35] F. Poirier,et al. Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. , 2000, Glycobiology.
[36] O. Suzuki,et al. Phaseolus vulgaris leukoagglutinating lectin‐binding reactivity in human diffuse large B‐cell lymphoma and its relevance to the patient’s clinical outcome: Lectin histochemistry and lectin blot analysis , 1999, Pathology international.
[37] P. Stewart,et al. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. , 1999, Journal of immunology.
[38] M. Yao,et al. N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice. , 1999, Journal of experimental & clinical cancer research : CR.
[39] Jürgen Bajorath,et al. Analysis of Fas–ligand interactions using a molecular model of the receptor–ligand interface , 1999, J. Comput. Aided Mol. Des..
[40] M. Peter,et al. Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. , 1999, Glycobiology.
[41] M. Pawlita,et al. UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. , 1999, Science.
[42] F. Real,et al. Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. , 1998, The Biochemical journal.
[43] S. Han,et al. Apoptotic signal of Fas is not mediated by ceramide. , 1998, Blood.
[44] J. Marth,et al. Immune regulation by the ST6Gal sialyltransferase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Peter,et al. Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.
[46] J. Foidart,et al. Expression of Lamp‐1 and Lamp‐2 and their interactions with galectin‐3 in human tumor cells , 1998, International journal of cancer.
[47] S. Kelm,et al. Sialic Acids in Molecular and Cellular Interactions , 1997, International Review of Cytology.
[48] R. Aebersold,et al. Fas-induced apoptosis of T cells occurs independently of ceramide generation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Sillence,et al. Evidence against an early signalling role for ceramide in Fas-mediated apoptosis. , 1997, The Biochemical journal.
[50] K. Tasaki,et al. Analysis of lectin binding properties on human Burkitt's lymphoma cell lines that show high spontaneous metastasis to distant organs in SCID mice: The binding sites for soybean agglutinin lectin masked by sialylation are closely associated with metastatic lymphoma cells , 1996, Pathology international.
[51] A. Anel,et al. CPP32 inhibition prevents Fas‐induced ceramide generation and apoptosis in human cells , 1996, FEBS letters.
[52] H. Gross,et al. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid. , 1996, Blood.
[53] L. Baum,et al. Apoptosis of T cells mediated by galectin-1 , 1995, Nature.
[54] M. Peter,et al. Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. , 1995, Cell death and differentiation.
[55] I. Andó,et al. Effect of phytohaemagglutinin on CD45 in T cells. , 1994, Immunology letters.
[56] J. Dennis,et al. Sialylation and malignant potential in tumour cell glycosylation mutants. , 1994, Glycobiology.
[57] S. Hakomori,et al. Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. , 1994, The Journal of biological chemistry.
[58] Richard D. Cummings,et al. Galectins: A family of animal β-galactoside-binding lectins , 1994, Cell.
[59] N. Hayashi,et al. N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. , 1993, Cancer research.
[60] R. Bernacki,et al. Galaptin-mediated adhesion of human ovarian carcinoma A121 cells and detection of cellular galaptin-binding glycoproteins. , 1993, Cancer research.
[61] G. Freeman,et al. The HB-6, CDw75, and CD76 differentiation antigens are unique cell- surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase , 1992, The Journal of cell biology.
[62] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[63] J. Dennis,et al. Glycosylation-dependent collagen-binding activities of two membrane glycoproteins in MDAY-D2 tumor cells. , 1988, Cancer research.
[64] G. Hart,et al. Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction. , 1987, Journal of immunology.
[65] R. Kerbel,et al. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. , 1987, Science.
[66] J. Dennis,et al. Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. , 1983, Cancer research.
[67] L. Liotta,et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.
[68] J. Dennis,et al. Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin , 1982, Nature.
[69] C. Buck,et al. Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[70] L. Pinter-Brown. SGN-30: a basis for the effective treatment of CD30 positive hematopoietic malignancies. , 2008, Expert opinion on investigational drugs.
[71] K. Tasaki,et al. UDP-GlcNAc2-epimerase regulates cell surface sialylation and ceramide-induced cell death in human malignant lymphoma. , 2008, International journal of molecular medicine.
[72] O. Suzuki,et al. The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1. , 2006, International journal of oncology.
[73] T. Yoshii,et al. CD 29 and CD 7 Mediate Galectin-3-Induced Type II T-Cell Apoptosis , 2003 .
[74] G. Freeman,et al. The HB-6 , CDw 75 , and CD 76 Differentiation Antigens are Unique Cell-Surface Carbohydrate Determinants Generated by the ß-Galactoside a 2 , 6-Sialyltransferase , 2002 .
[75] J. Ewing,et al. Murine B cell differentiation is accompanied by programmed expression of multiple novel β-galactoside α2,6-sialyltransferase mRNA forms , 2000 .
[76] P. Schlag,et al. Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens. , 1998, Cancer detection and prevention.
[77] K. Konstantinov,et al. Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. , 1996, The American journal of pathology.
[78] S. Barondes,et al. Galectins: a family of animal beta-galactoside-binding lectins. , 1994, Cell.